Health Tech Has a Higher Bar To Meet Before It Hits The Market--And It Starts With the FDA

This is the web version of dot.LA's daily newsletter. Sign up to get the latest news on Southern California's tech, startup and venture capital scene. Earlier this week, West Hollywood-based startup Pearl announced that its Second Opinion product had become the first AI-enabled device cleared by the Food and Drug Administration to read dental x-rays. Using the power of artificial intelligence, Second Opinion is meant to help dentists find maladies they'd otherwise miss through the eye test. Getting FDA clearance is not easy, especially because Pearl had to prove its device could detect a variety of dental conditions (most medical devices have to prove only one capability).